In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa

Indian J Med Microbiol. 2012 Jan-Mar;30(1):34-8. doi: 10.4103/0255-0857.93020.

Abstract

Purpose: In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin were investigated by studying time-kill kinetics and post-antibiotic effect (PAE) against strains of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.

Method: Synergy was investigated at 0.5 ×, 1 × and 5 × MIC of antibiotics using time-kill curve method. PAEs were determined by the standard viable counting method where bacteria in the logarithmic phase of growth were exposed for 1 h to the antibiotics at 1 × or 20 × MIC, alone and in combinations. Synergy and additive effects were detected at 1 × MIC, at 24 h.

Results: Some of the strains produced an earlier synergistic effect at 12 h. No antagonism was observed. Colistin methanesulfonate and amikacin produced PAEs 1.16 ± 0.10 to 2.25 ± 0.16 h and 0.96 ± 0.15 to 2.69 ± 0.32 h, respectively. When the antibiotics were used in combination the PAEs were prolonged to a value of 3.88 ± 0.25 h. Consequently, the

Conclusions: Findings of this study may play useful role in selecting the appropriate combinations when a single agent is inadequate, and may have important information for optimizing the dose intervals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amikacin / pharmacokinetics*
  • Amikacin / pharmacology*
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / pharmacology
  • Colistin / analogs & derivatives*
  • Colistin / pharmacokinetics
  • Colistin / pharmacology
  • Cystic Fibrosis / complications
  • Drug Interactions
  • Drug Therapy, Combination / methods
  • Humans
  • Microbial Sensitivity Tests
  • Microbial Viability / drug effects
  • Pseudomonas Infections / microbiology*
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Amikacin
  • colistinmethanesulfonic acid
  • Colistin